Diagenode

EZH2 and KDM6B Expressions Are Associated with Specific EpigeneticSignatures during EMT in Non Small Cell Lung Carcinomas.


Lachat C. et al.

The role of Epigenetics in Epithelial Mesenchymal Transition (EMT) has recently emerged. Two epigenetic enzymes with paradoxical roles have previously been associated to EMT, EZH2 (Enhancer of Zeste 2 Polycomb Repressive Complex 2 (PRC2) Subunit), a lysine methyltranserase able to add the H3K27me3 mark, and the histone demethylase KDM6B (Lysine Demethylase 6B), which can remove the H3K27me3 mark. Nevertheless, it still remains unclear how these enzymes, with apparent opposite activities, could both promote EMT. In this study, we evaluated the function of these two enzymes using an EMT-inducible model, the lung cancer A549 cell line. ChIP-seq coupled with transcriptomic analysis showed that EZH2 and KDM6B were able to target and modulate the expression of different genes during EMT. Based on this analysis, we described INHBB, WTN5B, and ADAMTS6 as new EMT markers regulated by epigenetic modifications and directly implicated in EMT induction.

Tags
IP-Star
Antibody
iDeal ChIP-seq Kit for Histones

Share this article

Published
December, 2020

Source

Products used in this publication

  • ChIP kit icon
    C01010171
    Auto iDeal ChIP-seq kit for Histones
  • ChIP-seq Grade
    C15410039-50
    EZH2 polyclonal antibody
  • ChIP-seq Grade
    C15410174
    H3K27ac polyclonal antibody
  • ChIP-seq Grade
    C15410069
    H3K27me3 polyclonal antibody
  • Mouse IgG
    C15410206
    Rabbit IgG
  • Kit icon
    C03010010
    Auto IPure kit v2
  • Compact Automated System
    B03000002
    SX-8G IP-Star® Compact Automated System

ニュース

 すべてのニュースを見る


The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.


       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics